T-VEC plus ipilimumab safe, effective in advanced melanoma

Talimogene laherparepvec (T-VEC) combined with ipilimumab was more effective in treating advanced melanoma than either treatment alone, report Igor Puzanov, MD, of Vanderbilt University Medical Center in Nashville, Tenn., and coauthors. In a phase Ib trial of 19 patients with advanced melanoma,...
Source: Skin and Allergy News - Category: Dermatology Source Type: news